XML 44 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Parent Company Financial Information
12 Months Ended
Dec. 31, 2018
Parent Company Financial Information [Abstract]  
Parent Company Financial Information
22.          Parent Company Financial Information


Condensed Balance Sheets

 
 
December 31,
 
(In thousands)
 
2018
  
2017
 
Assets
      
Cash and cash equivalents
 
$
5,876
  
$
7,572
 
Equity securities, at estimated fair value
  
18,221
   
-
 
AFS securities, at estimated fair value
  
-
   
10,065
 
Trading securities
  
-
   
11,245
 
Investment in subsidiaries, on equity basis
  
1,117,350
   
1,048,908
 
Other assets
  
34,237
   
40,461
 
Total assets
 
$
1,175,684
  
$
1,118,251
 
Liabilities and Stockholders’ Equity
        
Total liabilities
 
$
157,775
  
$
160,074
 
Stockholders’ equity
  
1,017,909
   
958,177
 
Total liabilities and stockholders’ equity
 
$
1,175,684
  
$
1,118,251
 

Condensed Statements of Income

 
 
Years ended December 31,
 
(In thousands)
 
2018
  
2017
  
2016
 
Dividends from subsidiaries
 
$
43,000
  
$
38,300
  
$
10,200
 
Management fee from subsidiaries
  
7,907
   
99,319
   
95,244
 
Net securities gains
  
399
   
2,237
   
652
 
Interest, dividends and other income
  
905
   
928
   
976
 
Total revenue
 
$
52,211
  
$
140,784
  
$
107,072
 
Operating expenses
  
14,226
   
100,667
   
97,977
 
Income before income tax benefit and equity in undistributed income of subsidiaries
  
37,985
   
40,117
   
9,095
 
Income tax (benefit) expense
  
(1,608
)
  
2,233
   
(321
)
Dividends in excess of income (equity in undistributed income) of subsidiaries
  
72,973
   
44,267
   
68,993
 
Net income
 
$
112,566
  
$
82,151
  
$
78,409
 

Condensed Statements of Cash Flow

 
 
Years ended December 31,
 
(In thousands)
 
2018
  
2017
  
2016
 
Operating activities
         
Net income
 
$
112,566
  
$
82,151
  
$
78,409
 
Adjustments to reconcile net income to net cash provided by operating activities
            
Depreciation and amortization of premises and equipment
  
2,814
   
2,974
   
2,805
 
Excess tax (benefit) on stock-based compensation
  
(543
)
  
(1,769
)
  
(1,055
)
Stock-based compensation expense
  
3,936
   
3,644
   
4,378
 
Net securities gain
  
(399
)
  
(2,238
)
  
(652
)
Re-evaluation of deferred tax amounts from Tax Act
  
-
   
3,339
   
-
 
Equity in undistributed income of subsidiaries
  
(115,972
)
  
(82,567
)
  
(79,193
)
Cash dividend from subsidiaries
  
43,000
   
38,300
   
10,200
 
Bank owned life insurance income
  
(424
)
  
(328
)
  
(356
)
Net change in other assets and other liabilities
  
(6,124
)
  
(2,454
)
  
16,242
 
Net cash provided by operating activities
 
$
38,854
  
$
41,052
  
$
30,778
 
Investing activities
            
Proceeds on sales of equity securities
 
$
3,318
  
$
-
  
$
-
 
Purchases of equity securities
  
(2
)
  
-
   
-
 
Proceeds on sales and maturities of AFS securities
  
-
   
4,710
   
1,783
 
Purchases of AFS securities
  
-
   
(9
)
  
(580
)
Proceeds from settlement of bank owned life insurance
  
-
   
308
   
-
 
Net purchases of premises and equipment
  
-
   
(2,264
)
  
(3,083
)
Net cash provided by (used in) investing activities
 
$
3,316
  
$
2,745
  
$
(1,880
)
Financing activities
            
Proceeds from the issuance of shares to employee and other stock plans
 
$
1,296
  
$
3,309
  
$
6,032
 
Cash paid by employer for tax-withholding on stock issuance
  
(1,893
)
  
(3,582
)
  
(3,387
)
Purchases of treasury shares
  
-
   
-
   
(17,193
)
Cash dividends
  
(43,269
)
  
(40,104
)
  
(38,880
)
Net cash (used in) financing activities
 
$
(43,866
)
 
$
(40,377
)
 
$
(53,428
)
Net (decrease) increase in cash and cash equivalents
 
$
(1,696
)
 
$
3,420
  
$
(24,530
)
Cash and cash equivalents at beginning of year
  
7,572
   
4,152
   
28,682
 
Cash and cash equivalents at end of year
 
$
5,876
  
$
7,572
  
$
4,152
 

A statement of changes in stockholders’ equity has not been presented since it is the same as the consolidated statement of changes in stockholders’ equity previously presented.